Journal Article Summary
The article investigates how drospirenone, a contraceptive hormone, transfers into breast milk after daily administration in lactating women. This topic is important because many women seek effective contraceptive options while breastfeeding, and understanding the safety and transfer of hormones into breast milk is crucial for infant health. The study aims to provide insights into the pharmacokinetics of drospirenone, particularly its concentration in breast milk compared to maternal plasma levels.
In this study, twelve healthy lactating women participated, taking a daily dose of 4 mg drospirenone for seven days to reach a steady state. Blood and breast milk samples were collected at various intervals after the last dose to measure drospirenone levels. The findings revealed that, on average, about 18% of the drospirenone present in the mother's plasma was found in her breast milk, with a total transfer amounting to approximately 4478 ng over a 24-hour period. The study concluded that at the recommended dosage, drospirenone is unlikely to affect breastfed infants.
However, the study has limitations, including a small sample size and the fact that all participants were healthy lactating women, which may not represent all breastfeeding mothers. There were no serious adverse events reported, indicating a good safety profile for drospirenone. Patients should discuss any concerns about contraceptive use while breastfeeding with their healthcare provider to ensure the best choices for their individual circumstances and to monitor any potential effects on their infants.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Melka Dace, Kask Kalev, Colli Enrico, Regidor Pedro-Antonio. A single-arm study to evaluate the transfer of drospirenone to breast milk after reaching steady state, following oral administration of 4 mg drospirenone in healthy lactating female volunteers. Women's Health 2020. DOI: 10.1177/1745506520957192. PMID: 32903172. PMCID: PMC7485149.
Featured Pill Pals Product
Pill Pals - Pill Cutter, Crusher, Splitter, and Holder (3 in 1) --- Three in One
Pill Pals - Pill Cutter, Crusher, Splitter, and Holder (3 in 1) --- Three in One is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. No prescription required for eligible over-the-counter purchases.
